Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group

1. del Alcázar, E.
2. López-Ferrer, A.
3. Martínez-Doménech, Á.
4. Julià, M.
5. Ruiz-Villaverde, R.
6. Rodríguez Fernández-Freire, L.
7. Notario, J.
8. Llamas-Velasco, M.
9. Ferran, M.
10. Carrascosa, J.M.